192 related articles for article (PubMed ID: 33438331)
1. Dysbiosis in aspirin-exacerbated respiratory disease.
Cook KA; Domissy A; Simon RA; White AA; Modena BD
Int Forum Allergy Rhinol; 2021 Jul; 11(7):1116-1120. PubMed ID: 33438331
[No Abstract] [Full Text] [Related]
2. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
O'Brien EK; Jerschow E; Divekar RD
Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
[TBL] [Abstract][Full Text] [Related]
3. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
4. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Borgeat Kaeser A; Ribi C
Praxis (Bern 1994); 2017; 106(22):1243-1249. PubMed ID: 29088964
[No Abstract] [Full Text] [Related]
6. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
7. Not just snot: Local inflammatory profiles in patients with aspirin-exacerbated respiratory disease differ from patients with aspirin-tolerant chronic rhinosinusitis.
Chiang S; Yu SE; Athni TS; Bergmark RW; Maxfield AZ; Roditi RE; Buchheit KM; Lundberg M; Mitchell MB; Lee SE
Int Forum Allergy Rhinol; 2024 Jan; 14(1):110-113. PubMed ID: 37325975
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
10. Symptom Control of Patients With Chronic Rhinosinusitis With Nasal Polyps Under Maintenance Therapy With Daily Acetylsalicylic Acid.
Hahn J; Appel H; Scheithauer MO; Petereit F; Greve J; Lindemann J; Hoffmann TK; Veit JA; Sommer F
Am J Rhinol Allergy; 2020 Jul; 34(4):554-563. PubMed ID: 32208749
[TBL] [Abstract][Full Text] [Related]
11. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
12. Perioperative management and perceived risks of sinus surgery in patients with aspirin-exacerbated respiratory disease.
Wangberg H; Spierling Bagsic SR; Levy JM; White A
Int Forum Allergy Rhinol; 2021 Jul; 11(7):1132-1134. PubMed ID: 33723921
[No Abstract] [Full Text] [Related]
13. Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?
Levy JM; Smith TL
Laryngoscope; 2017 Apr; 127(4):776-777. PubMed ID: 27813100
[No Abstract] [Full Text] [Related]
14. Aspirin-exacerbated respiratory disease: burden of disease.
Chang JE; White A; Simon RA; Stevenson DD
Allergy Asthma Proc; 2012; 33(2):117-21. PubMed ID: 22525387
[TBL] [Abstract][Full Text] [Related]
15. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol J; Picado C
Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
[TBL] [Abstract][Full Text] [Related]
16. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
[TBL] [Abstract][Full Text] [Related]
17. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
18. Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease.
Dunn NM; Katial RK
Immunol Allergy Clin North Am; 2016 Aug; 36(3):503-14. PubMed ID: 27401622
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
D'Souza GE; Nwagu U; Barton B; Unsal AA; Rabinowitz MR; Rosen MR; Nyquist GG; Cohn J; Most J; Toskala EM
Int Forum Allergy Rhinol; 2022 Mar; 12(3):306-309. PubMed ID: 34719120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
